|
Michael S. Weiss, 40, has served as our Chairman and Chief Executive Officer since December 2002. From March 1999 to December 2002, Mr. Weiss served as Chief Executive Officer and Chairman and later as the Executive Chairman of ACCESS Oncology, Inc. a private biotechnology company that we acquired in February 2004 and that is dedicated to the in-licensing and development of clinical stage oncology drugs. Previously, from November 1993 to March 1999, Mr. Weiss served as Senior Managing Director of Paramount Capital, Inc., an NASD registered broker-dealer. Prior to that, Mr. Weiss was an attorney with the law firm of Cravath, Swaine & Moore LLP. From 1997 to 2005, Mr. Weiss served as director of Genta, Inc., a publicly traded biopharmaceutical company. Mr. Weiss currently serves as chairman of the board of directors of XTL Biopharmaceuticals Ltd., a position he has held since 2005. Mr. Weiss received a J.D. from Columbia Law School and a B.A. from the State University of New York at Albany. | 